United States Drug Discovery Services Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Drug Discovery Services Market reached US$ 15.58 billion in 2023 and is expected to reach US$ 46.52 billion by 2031, growing at a CAGR of 14.8% during the forecast period 2024-2031.

Key Development:

United States: Recent Industry Developments

✅ In September 2025, Eli Lilly and Company launched its AI/ML‐enabled discovery platform "TuneLab" to give smaller biotech firms access to advanced drug‐discovery models built on Lilly's decade‐plus research experience. The platform accelerates early-stage target identification and preclinical testing for novel therapeutics.

✅ In January 2025, Charles River Laboratories entered a partnership with NJ Bio, Inc. to combine end‐to‐end ADC discovery services with integrated chemistry and bioconjugation capabilities. The collaboration aims to accelerate antibody‐drug‐conjugate (ADC) development from concept to clinic.

Japan: Recent Industry Developments

✅ In June 2025, Mitsubishi Research Institute and Astellas Pharma Inc. agreed on a memorandum of understanding to support Japanese drug‐discovery startups via the MEDISO programme, providing access to labs, corporate networks, and global development pathways. The initiative aims to accelerate early-stage drug innovation in Japan.

✅ In June 2025, the Development Bank of Japan (DBJ) invested through its "Startups & Innovation Fund" in drug‐discovery and life‐sciences ventures. The funding strengthens early-stage biotech startups and promotes innovation in Japan's pharmaceutical ecosystem.

✅ In March 2025, two portfolio companies of UTokyo Innovation Platform Co., Ltd. were selected in the FY2024 round of Japan Agency for Medical Research and Development (AMED) "Strengthening Program for Pharmaceutical Startup Ecosystem." The program supports early-stage small-molecule and ADC programs in Japan.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/drug-discovery-services-market?sb

Recent Mergers and acquisitions:

United States: Recent M&A Developments

✅ In October 2025, Thermo Fisher Scientific agreed to acquire Clario, a U.S. clinical‐services and data specialist, for up to USD 9.4 billion. The acquisition strengthens Thermo Fisher's drug‐development and clinical trial support capabilities.

✅ In February 2025, Belgium-based Ardena acquired a drug‐product manufacturing facility in New Jersey from Catalent, Inc., expanding its U.S. discovery-to-manufacturing service offerings and enhancing bioanalytical and formulation capabilities for drug discovery clients.

Japan: Recent M&A Developments

✅ In March 2025, Taiho Pharmaceutical entered into a definitive agreement to acquire Swiss ADC-technology firm Araris Biotech AG, with the total deal value up to USD 740 million including milestones. The acquisition enhances Taiho's drug‐discovery services and biologics/ADC pipeline.

✅ In January 2025, a Japanese life sciences venture capital consortium facilitated the acquisition of select early-stage drug-discovery assets from a domestic biotech startup. This move supports scaling promising discovery platforms and technology transfer to larger pharmaceutical firms.

Key Players:

=> Piramal Pharma Solutions, Biopta, Charles River Laboratories International, Domainex, Evotec AG, Albany Molecular Research Inc., GenScript, Pharmaceutical Product Development, LLC (PPD), WuXi AppTec, and Merck & Co., Inc., among others.

Growth Forecast Projected:

The Global Drug Discovery Services Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Drug Discovery Services Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=drug-discovery-services-market

Key Segments:

➥ By Process Type: Profiling & Lead Optimization, Screening, Assay Development, Cell Engineering

➥ By Service Type: Computational Chemistry, Medicinal Chemistry, ADME & DMPK, Biochemistry

➥ By Application Type: Oncology, Neurology, Metabolic & Inflammatory Disease, Immuno-Oncology

Regional Analysis for Drug Discovery Services Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Drug Discovery Services producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Drug Discovery Services revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/drug-discovery-services-market?sb

FAQ

What is the current size of the Drug Discovery Services Market?

A: In 2023, the Drug Discovery Services Market was valued at US$ 15.58 billion, reflecting its strong industry presence.

Q2: How large is the Drug Discovery Services Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Drug Discovery Services Market will grow to around US$ 46.52 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Drug Discovery Services Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 14.8% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.